Suchergebnisse - "Jutras-Aswad, Didier"

PubPharm (196)

1

Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use : Results from a randomized controlled trial

enthalten in: Addictive behaviors | 2024

von McAnulty, C. | Bastien, G. | Ledjiar, O. | +5

2

Digital Interventions for Recreational Cannabis Use Among Young Adults : Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies

enthalten in: Journal of medical Internet research | 2024

von Côté, J. | Chicoine, G. | Vinette, B. | +4

3

Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder : Results From a Pragmatic Randomized Controlled Trial

enthalten in: Journal of dual diagnosis | 2024

von Bastien, G. | Abboud, A. | McAnulty, C. | +8

4

Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions : A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale

enthalten in: Canadian journal of psychiatry. Revue canadienne de psychiatrie | 2024

von Coronado-Montoya, S. | Abdel-Baki, A. | Crockford, D. | +11

5

Perceptions and engagement of patients with chronic conditions on the use of medical cannabis : a scoping review

enthalten in: European journal of medical research | 2024

von Pomey, M. | Jutras-Aswad, D. | Paquette, J. | +10

6

Perceptions and engagement of patients with chronic conditions on the use of medical cannabis: a scoping review

enthalten in: European journal of medical research | 2024

von Pomey, M. | Jutras-Aswad, D. | Paquette, J. | +10

7

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy : Findings From a Canadian Pragmatic Trial

enthalten in: Canadian journal of psychiatry. Revue canadienne de psychiatrie | 2024

von Bahji, A. | Bastien, G. | Bach, P. | +5

8

Response to Hall et al. : Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness

enthalten in: Addiction (Abingdon, England) | 2024

von Sharafi, H. | Jutras-Aswad, D.

9

Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder : Findings from a Canadian pragmatic randomized trial

enthalten in: HIV medicine | 2024

von Socias, M. | Cui, Z. | Le Foll, B. | +4

10

Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder : Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA

enthalten in: Canadian journal of psychiatry. Revue canadienne de psychiatrie | 2024

von Bakouni, H. | Sharafi, H. | Drouin, S. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]